Melalite Cream 50gm
₹208.4*
MRP ₹231.5
10% off
₹196.5*
MRP ₹231.5
15% CB
₹35 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Melalite Cream 50gm is a combination medicine used in the treatment of hyperpigmentation and melasma (a type of skin problem). Hyperpigmentation is a common condition in which patches of skin become darker than the normal surrounding skin. Melasma also known as chloasma, is a common skin condition that causes brown patches on the face. It is more common in women than men. The discoloured (grey-brown) patches occur mostly on the forehead, chin, nose, and cheeks.
Melalite Cream 50gm is a combination of three drugs, namely: Hydroquinone (skin-lightening agent), Octyl methoxycinnamate, and Oxybenzone (organic compounds). Hydroquinone belongs to the class of skin-lightening agents that works by decreasing the amount of melanin (a skin pigment) that is responsible for the darkening of the skin. Octyl methoxycinnamate and Oxybenzone work by absorbing UV (ultraviolet) rays from the sun and protects the skin from sun damage.
Melalite Cream 50gm is only for external use. Use Melalite Cream 50gm as prescribed by your doctor. You are advised to use Melalite Cream 50gm for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience redness, irritation, itching, burning, or stinging sensation of the skin. Most of these side effects of Melalite Cream 50gm do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Melalite Cream 50gm or any other medicines, please tell your doctor. If you are pregnant, a nursing mother, or planning for pregnancy, it is advised to consult a doctor before using Melalite Cream 50gm. Melalite Cream 50gm is not recommended for children below 12 years of age unless prescribed by a doctor. Do not apply Melalite Cream 50gm on open wounds, dry, sunburned, windburned, chapped, or irritated skin. Avoid sun exposure while using Melalite Cream 50gm as it may make skin more sensitive to sunlight and cause sunburn. Wear protective clothing and use sunscreen while going out to protect your skin from sunburn.
Melalite Cream 50gm contains three drugs, namely: Hydroquinone, Octyl methoxycinnamate and Oxybenzone used in the treatment of hyperpigmentation. Hydroquinone belongs to the class of skin lightening agents that decreases the amount of melanin (a skin pigment) that is responsible for the darkening of the skin. Octyl methoxycinnamate and Oxybenzone absorbs UV (ultraviolet) rays from the sun and protects the skin from sun damage. Together, Melalite Cream 50gm lightens dark spots on the skin and protects from the harmful effects of UV rays.
If you are allergic to Melalite Cream 50gm or any other medicines, please tell your doctor. If you are pregnant, nursing mother or planning for pregnancy, it is advised to consult a doctor before using Melalite Cream 50gm. Melalite Cream 50gm is not recommended for children below 12 years of age unless prescribed by a doctor. Do not apply Melalite Cream 50gm on open wounds, dry, sunburned, windburned, chapped or irritated skin. Avoid sun exposure while using Melalite Cream 50gm as it may make skin more sensitive to sunlight and cause sunburn. Wear protective clothing and use sunscreen while going out to protect your skin from sunburn. Do not apply Melalite Cream 50gm in large amounts or use for prolonged time than prescribed as it does not give quick or better results but causes adverse effects.
Drug-Drug Interaction: No interactions found.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have a sulfite allergy, asthma, eczema (itchy, swelling of the skin), psoriasis (itchy, red scaly patches), kidney or liver disease, inform your doctor before taking Melalite Cream 50gm.
Please consult a dermatologist if the skin condition does not improve after 2 months of treatment with Melalite Cream 50gm.
Hyperpigmentation: It is a common condition in which patches of skin become darker than the normal surrounding skin. It may occur in small patches, over a large area, or affect the entire body. The main risk factors include exposure to the sun and inflammation, as both cases may increase the production of melanin (skin pigment).
Melasma: It is also known as chloasma, a common skin condition that causes brown patches on the face. The discolored (grey-brown) patches occur mostly on the forehead, chin, nose, and cheeks. Melasma may be caused due to sun exposure, hormone therapy, pregnancy, birth control pills, thyroid, or even stress. It is more common in women than men. It may occur in pregnant women due to hormonal changes during pregnancy and is called a ‘mask of pregnancy and fades away after pregnancy on its own or after stopping the usage of contraceptive pills. It can be treated by using skin-lightening creams, topical steroids, dermabrasion or chemical peels.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
The interaction of alcohol with Melalite Cream 50gm is unknown. Please consult a doctor before consuming alcohol while using Melalite Cream 50gm.
Pregnancy
Caution
Please consult a doctor if you are pregnant. Melalite Cream 50gm is given to a pregnant woman only if the doctor thinks benefits outweigh risks.
Breast Feeding
Caution
It is unknown whether Melalite Cream 50gm is excreted in human milk. Please consult a doctor before using Melalite Cream 50gm while breastfeeding.
Driving
Safe if prescribed
Melalite Cream 50gm usually does not affect your ability to drive or operate machinery.
Liver
Caution
If you have any concerns regarding the use of Melalite Cream 50gm in patients with liver problems, please consult a doctor.
Kidney
Caution
If you have any concerns regarding the use of Melalite Cream 50gm in patients with kidney problems, please consult a doctor.
Children
Caution
Melalite Cream 50gm is not recommended for children below 12 years of age unless advised by a doctor.